Södertälje, Sweden

Peter Johnström


 

Average Co-Inventor Count = 7.0

ph-index = 2

Forward Citations = 5(Granted Patents)


Location History:

  • Sodertalje, SE (2014)
  • Södertälje, SE (2012 - 2016)

Company Filing History:


Years Active: 2012-2016

Loading Chart...
Loading Chart...
3 patents (USPTO):Explore Patents

Title: Peter Johnström: Innovator in Alzheimer's Imaging

Introduction

Peter Johnström is a notable inventor based in Södertälje, Sweden. He has made significant contributions to the field of medical imaging, particularly in the diagnosis of Alzheimer's disease. With a total of 3 patents, his work focuses on developing compounds that enhance the imaging of amyloid deposits in the brain.

Latest Patents

Johnström's latest patents include innovative compounds that serve as precursors for imaging amyloid deposits in living patients. These novel derivatives are designed to facilitate the antemortem diagnosis of Alzheimer's disease through positron emission tomography (PET). The compounds derived from these precursors are crucial for measuring the clinical efficacy of therapeutic agents aimed at treating Alzheimer's disease. Additionally, his patents disclose these precursor compounds in crystalline form, further enhancing their utility in medical applications.

Career Highlights

Peter Johnström is currently associated with AstraZeneca AB, a leading global biopharmaceutical company. His work at AstraZeneca has allowed him to contribute to groundbreaking research in the field of neurodegenerative diseases. His innovative approach to imaging techniques has the potential to revolutionize how Alzheimer's disease is diagnosed and treated.

Collaborations

Johnström has collaborated with esteemed colleagues such as Seth Björk and Nils Anders Nilsson. These partnerships have fostered a collaborative environment that encourages the exchange of ideas and expertise, further advancing the field of medical imaging.

Conclusion

Peter Johnström's contributions to the field of Alzheimer's imaging are invaluable. His innovative patents and collaborative efforts position him as a key figure in the ongoing battle against neurodegenerative diseases.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…